In a sodium‑sensitive hypertensive patient with elevated plasma aldosterone and elevated renin, what is the next step in evaluation and management?

High Aldosterone with High Renin: Evaluation and Management

This Pattern Does NOT Represent Primary Aldosteronism

In a patient with elevated aldosterone AND elevated renin, primary aldosteronism is effectively ruled out, and you should immediately redirect your evaluation toward secondary causes of hyperreninemia, most commonly renovascular hypertension. 1

Primary aldosteronism characteristically presents with elevated or inappropriately normal aldosterone combined with suppressed renin due to aldosterone-mediated sodium retention and volume expansion. 1, 2 When both hormones are elevated together, the aldosterone-to-renin ratio (ARR) will be low or normal, making primary aldosteronism biochemically implausible. 1

---

Understanding the Pathophysiology

Why This Pattern Occurs

• Elevated renin drives aldosterone secretion through the renin-angiotensin-aldosterone system, resulting in appropriately elevated aldosterone rather than autonomous production. 1
• Secondary hyperreninemia arises from conditions causing decreased renal perfusion, volume depletion, or renovascular disease. 1
• The aldosterone elevation is physiologically appropriate in response to high renin, not autonomous as seen in primary aldosteronism. 1

Rare Exception: Advanced Primary Aldosteronism with Renal Damage

• In severe, long-standing primary aldosteronism, hypertensive kidney damage (arteriolosclerosis) can cause renin to "escape" from suppression, resulting in normal or even elevated renin levels despite ongoing autonomous aldosterone production. 3
• These patients typically have severe refractory hypertension, elevated serum creatinine, and an ARR that remains elevated (>30) despite the unsuppressed renin, because aldosterone is disproportionately high. 3
• This scenario is uncommon and represents advanced disease with secondary hypertensive nephropathy. 3

---

Primary Differential Diagnosis

Renovascular Hypertension (Most Likely)

Renovascular disease is the leading diagnosis when renin is elevated with normal or elevated aldosterone. 1

• Renal artery stenosis from atherosclerosis (older patients, vascular risk factors) or fibromuscular dysplasia (younger women) causes decreased renal perfusion, triggering renin release. 1
• The elevated renin appropriately stimulates aldosterone production through angiotensin II. 1

Other Causes of Secondary Hyperreninemia

• Volume depletion from diuretics, vomiting, diarrhea, or hemorrhage 1
• Renin-secreting tumor (rare juxtaglomerular cell tumor) 1
• Malignant hypertension with severe vascular injury 1
• Congestive heart failure with reduced effective arterial volume 1

---

Diagnostic Workup

Step 1: Assess Medication Effects and Volume Status

• Discontinue or account for medications that elevate renin: diuretics, ACE inhibitors, ARBs, direct renin inhibitors, calcium channel blockers. 1
• Evaluate for volume depletion: orthostatic vital signs, recent diuretic use, gastrointestinal losses. 1
• If volume depletion or medication effects explain the pattern, correct these factors and retest. 1

Step 2: Evaluate Renal Function and Structure

• Serum creatinine, eGFR, and urinary albumin-to-creatinine ratio to assess kidney function and damage. 1
• Renal Doppler ultrasound as the first-line non-invasive imaging study to screen for renal artery stenosis. 1
• CT angiography or MRI angiography of the renal arteries to definitively identify and characterize stenosis if Doppler is positive or clinical suspicion is high. 1

Step 3: Consider Adrenal Imaging Only If ARR Remains Elevated

• If the ARR is >30 despite elevated renin (suggesting disproportionately high aldosterone), consider the rare scenario of primary aldosteronism with secondary renal damage. 3
• In this case, proceed with non-contrast CT of the adrenal glands and confirmatory testing (saline suppression or oral salt loading) as you would for typical primary aldosteronism. 4, 3
• These patients often have elevated serum creatinine and severe hypertension, distinguishing them from uncomplicated renovascular disease. 3

---

Management Strategy

For Renovascular Hypertension (Atherosclerotic)

Optimal medical therapy is the primary treatment approach and is equally effective as revascularization in most cases. 1

• RAS blockade (ACE inhibitor or ARB) as first-line therapy, with close monitoring of creatinine and potassium. 1
• High-intensity statin for atherosclerotic disease. 1
• Antiplatelet therapy (aspirin) for cardiovascular risk reduction. 1
• Avoid routine stenting of unilateral atherosclerotic renal artery stenosis, as high-quality RCT evidence shows no benefit over medical therapy alone. 1

Indications for Renal Artery Revascularization

Reserve revascularization for specific scenarios: 1

• Refractory hypertension despite maximal medical therapy
• Progressive renal function decline attributable to stenosis
• Recurrent flash pulmonary edema suggesting bilateral disease or stenosis in a solitary kidney

For Fibromuscular Dysplasia

• Percutaneous renal artery angioplasty without stenting is the preferred treatment, with higher success rates than atherosclerotic disease. 1

For Primary Aldosteronism with Renal Damage (Rare)

• Cautious spironolactone therapy (starting at 50–100 mg daily) is indicated, but monitor closely for hyperkalemia and rising creatinine due to reduced GFR. 3
• Unilateral adrenalectomy can still cure hyperaldosteronism even in advanced cases, though hypertension may persist due to irreversible vascular remodeling. 3
• Early specific treatment is critical to prevent further renal deterioration. 3

---

Critical Pitfalls to Avoid

• Do not pursue primary aldosteronism workup (confirmatory testing, adrenal venous sampling) when aldosterone is normal or mildly elevated and renin is high, as the ARR will be low and not diagnostic. 1
• Do not start RAS blockers without close monitoring in suspected bilateral renal artery stenosis, as acute kidney injury can occur. 1
• Do not overlook medication effects on renin levels: beta-blockers and NSAIDs suppress renin (causing false-negative ARR), while diuretics, ACE inhibitors, and ARBs elevate renin (causing false-positive high renin). 1
• Do not routinely stent unilateral atherosclerotic renal artery stenosis, as medical therapy is equally effective based on high-quality RCT evidence. 1
• Do not assume normal potassium excludes pathology: hypokalemia is absent in ~50% of primary aldosteronism cases and is not a reliable screening trigger. 4

---

When to Suspect the Rare Exception (Primary Aldosteronism with Renal Damage)

Consider this diagnosis if: 3

• ARR remains >30 despite elevated renin (aldosterone is disproportionately high)
• Severe, refractory hypertension requiring multiple agents
• Elevated serum creatinine or evidence of hypertensive nephropathy
• Strong clinical suspicion for primary aldosteronism (resistant hypertension, adrenal mass, family history)

In this scenario, proceed with confirmatory testing and adrenal imaging as outlined in primary aldosteronism guidelines, but anticipate that spironolactone may cause significant hyperkalemia and creatinine elevation due to impaired renal function. 3